Influenza B Virus Tokio 53/99
文献支持

Influenza B Virus Tokio 53/99

收藏
  • ¥1080 - 37191
  • Prospecbio
  • 以色列
  • iha-017
  • 2025年07月13日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      for future use below -18°C

    • 保质期

      See instructions

    • 英文名

      Tokio 53/99

    • 库存

      常规产品有备货

    • 供应商

      上海经科化学科技有限公司

    • CAS号

    • 规格

      10ug/50ug/1mg

    规格:10ug产品价格:¥1080.0
    规格:50ug产品价格:¥2415.0
    规格:1mg产品价格:¥37191.0

    Influenza B Virus Tokio 53/99

    CATALOGUE NUMBER

    IHA-017

    INTRODUCTION

    Influenza-B virus is a genus in the virusfamily Orthomyxoviridae. The only species in this genus is called "Influenza B virus". Influenza B virus only infects humansand seals. This limited host range is apparently in contrast with those caused by the similar Influenza virus Aas both mutate by both genetic drift and reassortment. Influenza-B virus evolves slower than A viruses and faster than C viruses. Influenza-B virus mutates at a rate 2-3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible. The Influenza B virus capsidis enveloped while its virionconsists of a matrix protein + envelope + nucleoprotein complex + nucleocapsid, and a polymerasecomplex. Influenza B is sometimes spherical and sometimes filamentous. Its 500 or so surface projections are made of hemagglutinin and neuraminidase.
    The Influenza B virus is 14648 nucleotideslong and consists of eight segments of linear negative-sense, single-stranded RNA. The multipartite genome is encapsidated, each segment in a separate nucleocapsid, and the nucleocapsids are surrounded by one envelope.

    DESCRIPTION

    Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokio/53/99. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

    INACTIVATION

    Thimerosal and beta propiolactone treatment
    This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.

    PHYSICAL APPEARANCE

    Sterile Filtered colorless solution.

    FORMULATION

    The B/Tokio/53/99solution (1.7mg/ml) contains STE, 0.1% sodium azide (NaN3) and 0.005% thimerosal.

    STABILITY

    B/Tokio/53/99 although stable 4°C for 4 weeks, should be stored below -18°C.
    Please prevent freeze-thaw cycles.

    IMMUNOLOGICAL ACTIVITY

    Serological studies of influenza B virus, immunogen for antibody production.
    Tested with anti-influenza B monoclonal antibodies in ELISA.

    PURITY

    Greater than 90.0% as determined byAnalysis by SDS-PAGE.

    SAFETY DATA SHEET

    SDS

    USAGE

    ProSpec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献

    Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokio/53/99. The Influenza B Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1820.80
    广州威佳科技有限公司
    2025年07月08日询价
    $50
    安诺伦(北京)生物科技有限公司
    2025年07月15日询价
    ¥7920
    武汉博欧特生物科技有限公司
    2025年07月08日询价
    ¥9053.10
    北京孚博生物科技有限公司
    2025年07月12日询价
    ¥3149
    上海北诺生物科技有限公司
    2025年05月27日询价
    文献支持
    Influenza B Virus Tokio 53/99
    ¥1080 - 37191